Discounted Cash Flow (DCF) Analysis Unlevered
Novacyt S.A. (ALNOV.PA)
0.49 €
-0.00 (-0.61%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 13.28 | 12.37 | 11.18 | 277.20 | 95.78 | 646.16 | 4,359.23 | 29,408.82 | 198,401.60 | 1,338,482.65 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
EBITDA | -2.64 | -2.30 | -3.16 | 174.98 | -1.71 | -7.03 | -47.44 | -320.04 | -2,159.12 | -14,566.12 |
EBITDA (%) | ||||||||||
EBIT | -3.77 | -3.63 | -4.70 | 166.78 | -9.59 | -64.16 | -432.82 | -2,919.95 | -19,698.93 | -132,895.49 |
EBIT (%) | ||||||||||
Depreciation | 1.12 | 1.32 | 1.55 | 8.20 | 7.88 | 57.12 | 385.38 | 2,599.90 | 17,539.81 | 118,329.38 |
Depreciation (%) |
Balance Sheet Data
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Total Cash | 3.87 | 1.03 | 1.55 | 91.77 | 101.76 | 246.40 | 1,662.31 | 11,214.49 | 75,656.64 | 510,404.69 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | - | - | - | - | - | - | - | - | - | - |
Account Receivables (%) | ||||||||||
Inventories | 1.72 | 2.12 | 2.08 | 29.89 | 11.46 | 92.38 | 623.23 | 4,204.50 | 28,364.96 | 191,359.36 |
Inventories (%) | ||||||||||
Accounts Payable | 1.55 | 2.50 | 1.79 | 5.23 | 1.36 | 66.10 | 445.94 | 3,008.47 | 20,296.14 | 136,924.43 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -0.87 | -0.62 | -0.29 | -1.18 | -4.10 | -24.30 | -163.91 | -1,105.77 | -7,459.92 | -50,327.07 |
Capital Expenditure (%) |
Weighted Average Cost Of Capital
Share price | $ 0.49 |
---|---|
Beta | -2.222 |
Diluted Shares Outstanding | 79.87 |
Cost of Debt | |
Tax Rate | 1.03 |
After-tax Cost of Debt | 12.65% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | -6.706 |
Total Debt | 1.87 |
Total Equity | 39.13 |
Total Capital | 41 |
Debt Weighting | 4.56 |
Equity Weighting | 95.44 |
Wacc |
Build Up Free Cash
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 13.28 | 12.37 | 11.18 | 277.20 | 95.78 | 646.16 | 4,359.23 | 29,408.82 | 198,401.60 | 1,338,482.65 |
---|---|---|---|---|---|---|---|---|---|---|
EBITDA | -2.64 | -2.30 | -3.16 | 174.98 | -1.71 | -7.03 | -47.44 | -320.04 | -2,159.12 | -14,566.12 |
EBIT | -3.77 | -3.63 | -4.70 | 166.78 | -9.59 | -64.16 | -432.82 | -2,919.95 | -19,698.93 | -132,895.49 |
Tax Rate | 0.04% | -127.79% | -67.72% | 19.83% | 1.03% | -34.92% | -34.92% | -34.92% | -34.92% | -34.92% |
EBIAT | -3.77 | -8.26 | -7.89 | 133.72 | -9.49 | -86.56 | -583.98 | -3,939.72 | -26,578.63 | -179,308.24 |
Depreciation | 1.12 | 1.32 | 1.55 | 8.20 | 7.88 | 57.12 | 385.38 | 2,599.90 | 17,539.81 | 118,329.38 |
Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
Inventories | - | -0.39 | 0.03 | -27.80 | 18.43 | -80.92 | -530.85 | -3,581.27 | -24,160.45 | -162,994.40 |
Accounts Payable | - | 0.95 | -0.71 | 3.44 | -3.87 | 64.74 | 379.84 | 2,562.53 | 17,287.67 | 116,628.30 |
Capital Expenditure | -0.87 | -0.62 | -0.29 | -1.18 | -4.10 | -24.30 | -163.91 | -1,105.77 | -7,459.92 | -50,327.07 |
UFCF | -3.51 | -7 | -7.31 | 116.37 | 8.85 | -69.91 | -513.51 | -3,464.33 | -23,371.53 | -157,672.03 |
WACC | ||||||||||
PV UFCF | -74.24 | -578.94 | -4,147.09 | -29,706.56 | -212,794.91 | |||||
SUM PV UFCF | -247,301.74 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | -5.82 |
Free cash flow (t + 1) | -160,825.48 |
Terminal Value | 2,056,591.75 |
Present Value of Terminal Value | 2,775,585.82 |
Intrinsic Value
Enterprise Value | 2,528,284.08 |
---|---|
Net Debt | -99.88 |
Equity Value | 2,528,383.95 |
Shares Outstanding | 79.87 |
Equity Value Per Share | 31,657.30 |